ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 150 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 24.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $869,000 | +59.2% | 46,060 | -0.7% | 0.00% | +100.0% |
| Q2 2019 | $546,000 | +7.7% | 46,382 | +24.8% | 0.00% | 0.0% |
| Q1 2019 | $507,000 | +29.0% | 37,152 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $393,000 | -39.0% | 38,356 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $644,000 | +7.3% | 38,651 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $600,000 | +16.5% | 37,955 | -6.3% | 0.00% | 0.0% |
| Q1 2018 | $515,000 | +5.3% | 40,525 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $489,000 | -5.0% | 42,704 | +1.5% | 0.00% | 0.0% |
| Q3 2017 | $515,000 | +53.7% | 42,060 | +43.7% | 0.00% | +100.0% |
| Q2 2017 | $335,000 | -44.2% | 29,276 | +1.5% | 0.00% | -50.0% |
| Q1 2017 | $600,000 | +7.1% | 28,849 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $560,000 | -99.9% | 26,939 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $885,085,000 | +31.4% | 27,009 | +0.2% | 0.00% | +33.3% |
| Q2 2016 | $673,391,000 | +102.8% | 26,968 | +98.7% | 0.00% | +200.0% |
| Q1 2016 | $332,000,000 | -16.8% | 13,574 | +12.2% | 0.00% | -50.0% |
| Q4 2015 | $399,000,000 | +100403.8% | 12,093 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $397,000 | -99.9% | 12,114 | +0.1% | 0.00% | -33.3% |
| Q2 2015 | $640,937,000 | +341.4% | 12,100 | +140.5% | 0.00% | +200.0% |
| Q1 2015 | $145,195,000 | -0.8% | 5,031 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $146,352,000 | +120.7% | 5,031 | -3.8% | 0.00% | – |
| Q3 2014 | $66,304,000 | -36.9% | 5,229 | -0.1% | 0.00% | – |
| Q2 2014 | $105,026,000 | – | 5,233 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |